Prevalence and appropriateness of indwelling urinary catheters in Japanese hospital wards: a multicenter point prevalence study.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
21 Feb 2022
Historique:
received: 15 10 2021
accepted: 16 02 2022
entrez: 22 2 2022
pubmed: 23 2 2022
medline: 24 2 2022
Statut: epublish

Résumé

Indwelling urinary catheters are commonly used in hospitalized patients, which can lead to the development of urinary catheter complications, including catheter-associated urinary tract infection (CAUTI). Limited reports on the appropriateness of urinary catheter use exist in Japan. This study investigated the prevalence and appropriateness of indwelling urinary catheters, and the incidence of CAUTI in non-intensive care unit (non-ICU) wards in Japanese hospitals. This prospective observational study was conducted in 7 non-ICU wards from 6 hospitals in Japan from October 2017 to June 2018. At each hospital the study teams evaluated urinary catheter prevalence through in-person bedside evaluation for at least 5 days of each week for 3 months. Catheter associated urinary tract infection (CAUTI) incidence and appropriateness of catheter use was collected via chart review. We assessed 710 catheter-days over 5528 patient-days. The mean prevalence of indwelling urinary catheter use in participating wards was 13% (range: 5% to 19%), while the mean incidence of CAUTI was 9.86 per 1000 catheter-days (range: 0 to 33.90). Approximately 66% of the urinary catheter days assessed had an appropriate indication for use (range: 17% to 81%). A physician's order for catheter placement was present in only 10% of catheterized patients. This multicenter study provides epidemiological information about the appropriate use of urinary catheters in Japanese non-ICU wards. A multimodal intervention may help improve the appropriate use of urinary catheters.

Sections du résumé

BACKGROUND BACKGROUND
Indwelling urinary catheters are commonly used in hospitalized patients, which can lead to the development of urinary catheter complications, including catheter-associated urinary tract infection (CAUTI). Limited reports on the appropriateness of urinary catheter use exist in Japan. This study investigated the prevalence and appropriateness of indwelling urinary catheters, and the incidence of CAUTI in non-intensive care unit (non-ICU) wards in Japanese hospitals.
METHODS METHODS
This prospective observational study was conducted in 7 non-ICU wards from 6 hospitals in Japan from October 2017 to June 2018. At each hospital the study teams evaluated urinary catheter prevalence through in-person bedside evaluation for at least 5 days of each week for 3 months. Catheter associated urinary tract infection (CAUTI) incidence and appropriateness of catheter use was collected via chart review.
RESULTS RESULTS
We assessed 710 catheter-days over 5528 patient-days. The mean prevalence of indwelling urinary catheter use in participating wards was 13% (range: 5% to 19%), while the mean incidence of CAUTI was 9.86 per 1000 catheter-days (range: 0 to 33.90). Approximately 66% of the urinary catheter days assessed had an appropriate indication for use (range: 17% to 81%). A physician's order for catheter placement was present in only 10% of catheterized patients.
CONCLUSION CONCLUSIONS
This multicenter study provides epidemiological information about the appropriate use of urinary catheters in Japanese non-ICU wards. A multimodal intervention may help improve the appropriate use of urinary catheters.

Identifiants

pubmed: 35189844
doi: 10.1186/s12879-022-07162-3
pii: 10.1186/s12879-022-07162-3
pmc: PMC8862324
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

175

Informations de copyright

© 2022. The Author(s).

Références

Ann Intern Med. 2015 May 5;162(9 Suppl):S1-34
pubmed: 25938928
Am J Infect Control. 2019 Jan;47(1):65-68
pubmed: 30172609
PLoS One. 2017 Oct 9;12(10):e0185369
pubmed: 28991927
BMC Urol. 2012 Sep 06;12:25
pubmed: 22954383
J Eval Clin Pract. 2021 Oct 10;:
pubmed: 34628703
BMC Health Serv Res. 2018 Aug 16;18(1):642
pubmed: 30115051
Lancet Infect Dis. 2020 Jul;20(7):864-872
pubmed: 32151333
BMJ Qual Saf. 2014 Apr;23(4):277-89
pubmed: 24077850
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1497-1499
pubmed: 33517921
Infect Dis Health. 2020 Nov;25(4):262-267
pubmed: 32595104
Infect Control Hosp Epidemiol. 2018 Jan;39(1):77-84
pubmed: 29249212
JAMA Intern Med. 2018 Aug 1;178(8):1078-1085
pubmed: 29971436
Clin Infect Dis. 2017 May 15;64(suppl_2):S127-S130
pubmed: 28475778
Infect Control Hosp Epidemiol. 2010 Apr;31(4):319-26
pubmed: 20156062
BMJ Qual Saf. 2013 Dec;22(12):984-8
pubmed: 23744536
N Engl J Med. 2016 Jun 2;374(22):2111-9
pubmed: 27248619
N Engl J Med. 2018 Nov 1;379(18):1732-1744
pubmed: 30380384
Infect Control Hosp Epidemiol. 2019 Nov;40(11):1272-1274
pubmed: 31558172

Auteurs

Kohta Katayama (K)

Department of General Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda, Narita, Chiba, 286-8520, Japan. pine77717@gmail.com.

Jennifer Meddings (J)

Center for Clinical Management Research, U.S. Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Division of General Pediatrics, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA.

Sanjay Saint (S)

Center for Clinical Management Research, U.S. Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA.
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

Karen E Fowler (KE)

Center for Clinical Management Research, U.S. Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA.

David Ratz (D)

Center for Clinical Management Research, U.S. Department of Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA.

Yasuaki Tagashira (Y)

Division of Infectious Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.

Yumi Kawamura (Y)

Department of General Internal Medicine and Emergency Medicine, Mimihara General Hospital, Sakai, Osaka, Japan.

Tatsuya Fujikawa (T)

Department of General Internal Medicine, Mitoyo General Hospital, Kanonji, Kagawa, Japan.

Sho Nishiguchi (S)

Department of General Internal Medicine, Shonan Kamakura General Hospital, Kamakura, Japan.

Naomi Kayauchi (N)

Department of Infection Control, Mito Kyodo General Hospital, Mito, Ibaraki, Japan.

Nobumasa Takagaki (N)

Nobumasa Clinic, Kyoto, Japan.

Yasuharu Tokuda (Y)

Muribushi Okinawa Center for Teaching Hospitals, Urasoe, Okinawa, Japan.

Akira Kuriyama (A)

Emergency and Critical Care Center, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH